06.05.2026

A New Pill Finally Offers Hope for Pancreatic Cancer

A medical breakthrough is doubling the survival time for patients with one of the most aggressive forms of cancer. A new pill taken daily to treat pancreatic cancer has shown positive results in a study with 500 patients. Scientists found the drug reduced the risk of death by 60% compared with chemotherapy. Dr. Mark Goldsmith, CEO of the biotech company that funded the study, joins the show.



About the Program

PBS and WNET, in collaboration with CNN, launched the new one-hour late-night public affairs series Amanpour and Company on Monday, September 10 on PBS (check local listings).
The new series features wide-ranging, in-depth conversations with global thought leaders and cultural influencers on the issues and trends impacting the world each day, from politics, business and technology to arts, science and sports.  Christiane Amanpour leads the conversation on global and domestic news from London with contributions by prominent journalists Walter Isaacson, Michel Martin and Hari Sreenivasan from the Tisch WNET Studios at Lincoln Center in New York City.

Major support for Amanpour and Company is provided by the Anderson Family Endowment, Jim Attwood and Leslie Williams, Candace King Weir, the Sylvia A. and Simon B. Poyta Programming Endowment to Fight Antisemitism, the Straus Family Foundation, The Peter G. Peterson & Joan Ganz Cooney Fund, Charles Rosenblum, Monique Schoen Warshaw, Koo and Patricia Yuen and Barbara Hope Zuckerberg.